Massachusetts Financial Services’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
Other funds holding TXMD
Massachusetts Financial Services's TXMD Position: Q4 2017 in Review
Massachusetts Financial Services sold out of TherapeuticsMD (TXMD) in Q4 2017, closing a stake of 8,866 shares — an estimated $2.35M sold.
Massachusetts Financial Services first reported a position in TXMD in Q1 2014 and held it in 15 quarters. The position peaked at $27.6M in Q1 2014. 144 funds tracked by Wall St. Rank hold TXMD as of Q4 2017.
- Massachusetts Financial Services reported no remaining TherapeuticsMD position as of Q4 2017 after selling out during the quarter.
- Massachusetts Financial Services sold 8,866 TherapeuticsMD shares in Q4 2017, an estimated $2.35M.
- Massachusetts Financial Services first reported a position in TherapeuticsMD in Q1 2014 and held it in 15 quarters.
- Massachusetts Financial Services's TherapeuticsMD position peaked at $27.6M in Q1 2014.
- 144 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2017.
Based on Massachusetts Financial Services's 13F filing for Q4 2017, filed 14 Feb 2018.